• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Molecular pathogen profiling of COVID-19 coinfections

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2024 Dec 19;24(1):1451.
doi: 10.1186/s12879-024-10347-7. Molecular pathogen profiling of COVID-19 coinfections

Yanping Dai[SUP] #[/SUP][SUP] 1 [/SUP], Shuan Tao[SUP] #[/SUP][SUP] 1 [/SUP], Huanhuan Ying[SUP] 1 [/SUP], Qianqian Fang[SUP] 1 [/SUP], Jingping Kong[SUP] 1 [/SUP], Fei Guo[SUP] 1 [/SUP], Yong Yang[SUP] 1 [/SUP], Peng Cao[SUP] 1 [/SUP], Ying Zhou[SUP] 1 [/SUP], Weijiang Jin[SUP] 1 [/SUP], Wei Liang[SUP] 2 3 [/SUP]



Affiliations
Abstract

Objective: This study aims to investigate the prevalence, pathogen spectrum, clinical characteristics, and prognosis-related factors of other respiratory pathogens in COVID-19-infected patients, and to explore the application of molecular detection methods in the epidemiological investigation of multiple pathogen infections.
Methods: Respiratory samples and clinical data from 384 patients with outpatient and inpatient respiratory infections were collected and analyzed. Multiplex PCR and capillary electrophoresis were conducted to detect the distribution characteristics of 26 pathogen species, comprising 13 viruses, 13 bacteria. Statistical analysis explored the relationship between pathogen distribution with COVID-19 development.
Results: There was no statistical difference in prognosis between the 230 COVID-19-positive patients and the 154 COVID-19-positive patients. COVID-19 cases co-infected with other pathogens do not correlate with patient's age and gender. The main distribution of pathogens was mainly mecA (n = 62, 26.96%), followed by SPN(n = 61; 26.52%) and KP(n = 22; 9.57%). Compared with non-COVID-19 cases, COVID-19 infected patients showed a significantly higher mecA carrying rate (26.96% vs. 15.58%, P < 0.01), while there was no statistical difference for other pathogens. Regression analysis found that mecA and KP were independent risk factors for severe illnesses (mechanical ventilation, endotracheal intubation, ECOMO, etc.) or death in COVID-19 patients had 2.391 times and 3.722 times risk of severe disease or death compared with COVID-19 patients without mecA and KP.
Conclusion: COVID-19 patients show a higher mecA carrier rate than non-COVID-19 patients, and mecA and KP may increase the risk of severe disease or death in COVID-19 patients, which requires close attention.

Keywords: Klebsiella pneumoniae (KP); COVID-19; Epidemiology; Respiratory pathogens; mecA.

 
Back
Top Bottom